News
-
Stent trial proceeding
Monday | Jul 16 2012REVA Medical, a dual listed US-Australian research firm, has completed clinical enrolment for a clinical trial.
-
Atorvastatin 25% price cut
Monday | Jul 16 2012THE generics price war is continuing to hot up, with an unnamed atorvastatin sponsor having initiated.
-
FDA Plan B approval
Monday | Jul 16 2012THE US Food and Drug Administration has granted approval for Watson Pharmaceuticals’ generic version of Teva’s.
-
CM courses defended
Monday | Jul 16 2012AN ARTICLE published today in the Medical Journal of Australia strongly defends the teaching of complementary.
-
Guess that Gargle
Friday | Jul 13 2012BETADINE Sore Throat Gargle has launched a Guess that Gargle competition which gives people the chance.
-
Hunting headache solutions
Friday | Jul 13 2012A NEW survey currently being conducted by headache.com.au is hoping to shed light on the success.
-
EMA Committee call
Friday | Jul 13 2012THE European Medicines Agency is calling for expressions of interest from representatives of patient and healthcare-professional.
-
Arthritis warning
Friday | Jul 13 2012AUTHORITIES in the UK are warning arthritis patients to steer clear of “a potentially-dangerous unlicensed and.
-
Arthrotec generic
Friday | Jul 13 2012WATSON Laboratories has received US Food and Drug Administration approval for its diclofenac sodium and misoprostol.